1 |
small ubiquitin-like modifier
(1713 times)
|
Biochemistry (403 times)
|
SIM (56 times) PTMs (38 times) PTM (36 times)
|
2000 SUMO-1 conjugation to human DNA topoisomerase II isozymes.
|
2 |
Simulation of Urban MObility
(8 times)
|
Biosensing Techniques (7 times)
|
ADAS (1 time) AVs (1 time) C-ITSs (1 time)
|
2017 Towards Realistic Urban Traffic Experiments Using DFROUTER: Heuristic, Validation and Extensions.
|
3 |
small ubiquitin-like protein modifier
(7 times)
|
Science (2 times)
|
AML (1 time) APL (1 time) HHT (1 time)
|
2006 A Role for SUMO in meiotic chromosome synapsis.
|
4 |
small Ub-like modifier
(5 times)
|
Biochemistry (3 times)
|
Ub (4 times) ATG-8 (1 time) Atg8 (1 time)
|
2005 Post-translational regulation in plants employing a diverse set of polypeptide tags.
|
5 |
single-unoccupied molecular orbital
(4 times)
|
Chemistry (2 times)
|
SOMO (3 times) DFT (1 time) Fc (1 time)
|
2015 Organic Light-Emitting Diodes Using a Neutral pi Radical as Emitter: The Emission from a Doublet.
|
6 |
small ubiquitin-like protein
(4 times)
|
Biochemistry (2 times)
|
CARs (1 time) phy (1 time)
|
2001 LAF1, a MYB transcription activator for phytochrome A signaling.
|
7 |
small ubiquitin-like molecule
(3 times)
|
Biochemical Phenomena (1 time)
|
CID (1 time) CMC (1 time) DAPK1 (1 time)
|
2019 Regulation of the Expression of DAPK1 by SUMO Pathway.
|
8 |
SUMOylation
(3 times)
|
Molecular Biology (1 time)
|
AC (1 time) AID (1 time) BM (1 time)
|
2016 Identification of Substrates of Protein-Group SUMOylation.
|
9 |
susceptibility gradient mapping using the original resolution
(3 times)
|
Diagnostic Imaging (2 times)
|
GRASP (3 times) RF (2 times) MR (1 time)
|
2019 Positive visualization of MR-compatible nitinol stent using a susceptibility-based imaging technique.
|
10 |
SGM using the original resolution
(1 time)
|
Diagnostic Imaging (1 time)
|
SGM (1 time)
|
2011 Positive visualization of implanted devices with susceptibility gradient mapping using the original resolution.
|
11 |
simulation of the urban mobility
(1 time)
|
Biomedical Engineering (1 time)
|
CAVs (1 time) LCS (1 time) VSL (1 time)
|
2022 SWSCAV: Real-time traffic management using connected autonomous vehicles.
|
12 |
simulator
(1 time)
|
Environmental Health (1 time)
|
AI (1 time) GAs (1 time) MLE (1 time)
|
2022 Automating process design by coupling genetic algorithms with commercial simulators: a case study for hybrid MABR processes.
|
13 |
site in thesmall ubiquitin-like modifier
(1 time)
|
|
UBL (2 times)
|
2018 Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme.
|
14 |
small ubiquitin-like modifying polypeptides
(1 time)
|
Science (1 time)
|
---
|
2007 Sumoylation in axons triggers retrograde transport of the RNA-binding protein La.
|
15 |
small ubiquitin-like post-translational modifier
(1 time)
|
Nervous System Physiological Phenomena (1 time)
|
hiPSCs (1 time) RGCs (1 time) TFs (1 time)
|
2017 SoxC transcription factors in retinal development and regeneration.
|
16 |
Small-Ub-related MOdifier
(1 time)
|
Molecular Biology (1 time)
|
LECA (1 time) Ub (1 time) Ufm1 (1 time)
|
2014 The eukaryotic ancestor had a complex ubiquitin signaling system of archaeal origin.
|
17 |
Statistical Utilities for Microarray and Omics data
(1 time)
|
Neoplasms (1 time)
|
HNSCC (1 time)
|
2015 Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
|
18 |
Stress Ultrasonography in Morbid Obesity
(1 time)
|
Echocardiography (1 time)
|
CAD (1 time) SE (1 time)
|
2016 Stress echocardiography in patients with morbid obesity.
|
19 |
Stroke Unit Multicenter Observational
(1 time)
|
Brain (1 time)
|
rt-PA (1 time)
|
2008 Impact of the approval of intravenous recombinant tissue plasminogen activator therapy on the processes of acute stroke management in Japan: the Stroke Unit Multicenter Observational (SUMO) Study.
|
20 |
Suggested Upper Merged Ontology
(1 time)
|
Semantics (1 time)
|
ICF (1 time)
|
2012 An ontology-based exploration of the concepts and relationships in the activities and participation component of the international classification of functioning, disability and health.
|
21 |
SUMO-delta
(1 time)
|
Biochemistry (1 time)
|
NES (1 time) NLS (1 time)
|
2006 SUMO regulates the cytoplasmonuclear transport of its target protein Daxx.
|
22 |
SUMO-HisTag-TEV sequence
(1 time)
|
Chemistry (1 time)
|
NCL (1 time)
|
2019 Chemical Modification of the N Termini of Unprotected Peptides for Semisynthesis of Modified Proteins by Utilizing a Hydrophilic Protecting Group.
|
23 |
SUMO-SUMO polymers are dispensable for PCNA
(1 time)
|
Molecular Biology (1 time)
|
PCNA (1 time)
|
2007 Architecture and assembly of poly-SUMO chains on PCNA in Saccharomyces cerevisiae.
|
24 |
SUMO-tag can be cleaved by specific
(1 time)
|
Molecular Biology (1 time)
|
---
|
2008 SUMO fusion technology for enhanced protein production in prokaryotic and eukaryotic expression systems.
|
25 |
SUMOylation is a reversible post-translational modification, where a small peptide
(1 time)
|
Biology (1 time)
|
---
|
2010 Roles for SUMO modification during senescence.
|
26 |
Surveillance Monitor
(1 time)
|
Public Health (1 time)
|
AKTIN (1 time)
|
2021 [Real-time data from medical care settings to guide public health action].
|
27 |
Systems Understanding of Microbial Oxygen Metabolism
(1 time)
|
Microbiology (1 time)
|
SysMO (1 time)
|
2014 Towards a systems level understanding of the oxygen response of Escherichia coli.
|